Skip to content
Insider tapeFilings through Fri, Oct 9
Watchlist

Kurt J Hilzinger

Director at Outlook Therapeutics, Inc. (OTLK)

Purchase track record

Not enough history. Based on 1 purchase with a full 90 days of price history.

—
Avg. 90-day return+9.2%
vs. S&P 500+6.9%
Beat the market100%
Paper profit on buys+$64K
Total bought / sold$176K / $0

Reported trades

Filed Stock Type Shares Price Value Since
May 27SEC OTLKOutlook Therapeutics, Inc. Buy 400,000423,655 held (+1691%) $0.44 $176K +36.1%
  • Buy

    Director Kurt J Hilzinger bought $176K of OTLK at $0.44 — first open-market purchase in our records; raises the stake by 1691%.